The long non-coding RNA NEAT1 interacted with miR-101 modulates breast cancer growth by targeting EZH2

Archives of Biochemistry and Biophysics

Volumn 615, Issue , 2017, Pages 1-9

  Qian, Ke ^a   Liu, Gao ^a   Tang, Zhonghua ^a   Hu, Yibo ^a   Fang, Yu ^a   Chen, Zonglin ^a   Xu, Xundi ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Breast cancer; EZH2; lncRNA; miR 101; NEAT1

Indexed keywords

LONG UNTRANSLATED RNA; MICRORNA 101; NUCLEAR ENRICHED ABUNDANT TRANSCRIPT 1; TRANSCRIPTION FACTOR EZH2; UNCLASSIFIED DRUG; DNA; EZH2 PROTEIN, HUMAN; MICRORNA; MIRN101 MICRORNA, HUMAN;

ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER GROWTH; CELL GROWTH; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INTERACTIONS WITH RNA; LUNG CANCER; MTT ASSAY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; UPREGULATION; WESTERN BLOTTING; BREAST TUMOR; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; HUMAN GENOME; MCF-7 CELL LINE;

BREAST NEOPLASMS; CELL PROLIFERATION; DISEASE PROGRESSION; DNA; ENHANCER OF ZESTE HOMOLOG 2 PROTEIN; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HUMANS; MCF-7 CELLS; MICRORNAS; RNA, LONG NONCODING;

EID: 85008224833     PISSN: 00039861     EISSN: 10960384     Source Type: Journal    
DOI: 10.1016/j.abb.2016.12.011     Document Type: Article

References (26)

1. [1] Djebali, S., Davis, C.A., Merkel, A., Dobin, A., Lassmann, T., Mortazavi, A., Tanzer, A., Lagarde, J., Lin, W., Schlesinger, F., Xue, C., Marinov, G.K., Khatun, J., Williams, B.A., Zaleski, C., Rozowsky, J., Roder, M., Kokocinski, F., Abdelhamid, R.F., Alioto, T., Antoshechkin, I., Baer, M.T., Bar, N.S., Batut, P., Bell, K., Bell, I., Chakrabortty, S., Chen, X., Chrast, J., Curado, J., Derrien, T., Drenkow, J., Dumais, E., Dumais, J., Duttagupta, R., Falconnet, E., Fastuca, M., Fejes-Toth, K., Ferreira, P., Foissac, S., Fullwood, M.J., Gao, H., Gonzalez, D., Gordon, A., Gunawardena, H., Howald, C., Jha, S., Johnson, R., Kapranov, P., King, B., Kingswood, C., Luo, O.J., Park, E., Persaud, K., Preall, J.B., Ribeca, P., Risk, B., Robyr, D., Sammeth, M., Schaffer, L., See, L.H., Shahab, A., Skancke, J., Suzuki, A.M., Takahashi, H., Tilgner, H., Trout, D., Walters, N., Wang, H., Wrobel, J., Yu, Y., Ruan, X., Hayashizaki, Y., Harrow, J., Gerstein, M., Hubbard, T., Reymond, A., Antonarakis, S.E., Hannon, G., Giddings, M.C., Ruan, Y., Wold, B., Carninci, P., Guigo, R., Gingeras, T.R., Nature 489 (2012), 101–108.
2. [2] Martens-Uzunova, E.S., Bottcher, R., Croce, C.M., Jenster, G., Visakorpi, T., Calin, G.A., Eur. Urol. 65 (2014), 1140–1151.
3. [3] Ponting, C.P., Oliver, P.L., Reik, W., Cell 136 (2009), 629–641.
4. [4] Zhou, S., Wang, J., Zhang, Z., J. Cancer Res. Clin. Oncol. 140 (2014), 1989–1995.
5. [5] Zhang, K., Luo, Z., Zhang, Y., Zhang, L., Wu, L., Liu, L., Yang, J., Song, X., Liu, J., Cancer Biomark. 17 (2016), 187–194.
6. [6] Xiao, C., Wu, C.H., Hu, H.Z., Eur. Rev. Med. Pharmacol. Sci. 20 (2016), 2819–2824.
7. [7] XianGuo, C., ZongYao, H., Jun, Z., Song, F., GuangYue, L., LiGang, Z., KaiPing, Z., YangYang, Z., ChaoZhao, L., Oncotarget, 2016 Jun 15, 10.18632/oncotarget.10084 [Epub ahead of print].
8. [8] Sun, C., Li, S., Zhang, F., Xi, Y., Wang, L., Bi, Y., Li, D., Oncotarget, 7(32), 2016 Aug 9, 51784–51814, 10.18632/oncotarget.10108.
9. [9] Fu, J.W., Kong, Y., Sun, X., J. Cancer Res. Clin. Oncol. 142 (2016), 1571–1579.
10. [10] Shi, X., Sun, M., Liu, H., Yao, Y., Song, Y., Cancer Lett. 339 (2013), 159–166.
11. [11] Ke, H., Zhao, L., Feng, X., Xu, H., Zou, L., Yang, Q., Su, X., Peng, L., Jiao, B., Gene Regul. Syst. Bio 10 (2016), 11–17.
12. [12] Lo, P.K., Zhang, Y., Wolfson, B., Gernapudi, R., Yao, Y., Duru, N., Zhou, Q., Oncotarget, 7(40), 2016 Oct 4, 65067–65089, 10.18632/oncotarget.11364.
13. [13] Wu, X., Zeng, R., Wu, S., Zhong, J., Yang, L., Xu, J., Gene 557 (2015), 195–200.
14. [14] Zhao, L., Sun, Y., Hou, Y., Peng, Q., Wang, L., Luo, H., Tang, X., Zeng, Z., Liu, M., Int. J. Biochem. Cell Biol. 44 (2012), 2051–2059.
15. [15] Wang, L., Li, L., Guo, R., Li, X., Lu, Y., Guan, X., Gitau, S.C., Xu, C., Yang, B., Shan, H., Cell Physiol. Biochem. 34 (2014), 413–422.
16. [16] Liu, J., Pang, Y., Wang, H., Li, Y., Sun, X., Xu, F., Ren, H., Liu, D., Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 32 (2016), 299–303.
17. [17] Zheng, Y., Yin, L., Chen, H., Yang, S., Pan, C., Lu, S., Miao, M., Jiao, B., FEBS Lett. 586 (2012), 2396–2403.
18. [18] Fellenberg, J., Sahr, H., Kunz, P., Zhao, Z., Liu, L., Tichy, D., Herr, I., Cancer Lett. 371 (2016), 134–141.
19. [19] Alajez, N.M., Shi, W., Hui, A.B., Bruce, J., Lenarduzzi, M., Ito, E., Yue, S., O'Sullivan, B., Liu, F.F., Cell Death Dis., 1, 2010, e85.
20. [20] Chai, Y., Liu, J., Zhang, Z., Liu, L., Cancer Med. 5 (2016), 1588–1598.
21. [21] Zhen, L., Yun-Hui, L., Hong-Yu, D., Jun, M., Yi-Long, Y., Tumour Biol. 37 (2016), 673–683.
22. [22] Lu, Y., Li, T., Wei, G., Liu, L., Chen, Q., Xu, L., Zhang, K., Zeng, D., Liao, R., Tumour Biol., 37(9), 2016 Sep, 11733–11741 Epub 2016 Mar 28.
23. [23] Wang, X., Li, M., Wang, Z., Han, S., Tang, X., Ge, Y., Zhou, L., Zhou, C., Yuan, Q., Yang, M., J. Biol. Chem. 290 (2015), 3925–3935.
24. [24] Zhou, X., Xia, Y., Li, L., Zhang, G., Cancer Biol. Ther. 16 (2015), 160–169.
25. [25] Chen, J., Qin, Z., Jiang, Y., Wang, Y., He, Y., Dai, J., Jin, G., Ma, H., Hu, Z., Yin, Y., Shen, H., PLoS One, 9, 2014, e86319.
26. [26] Mu, Z., Li, H., Fernandez, S.V., Alpaugh, K.R., Zhang, R., Cristofanilli, M., J. Exp. Clin. Cancer Res., 32, 2013, 70.